GPs may be asked by their patients to issue prescriptions for nicotine eliquid formulations, so they can purchase and use iNRT products legally under current regulations. Under the TGA's Personal Importation Scheme, prescriptions for iNRT products imported for therapeutic purposes can authorise 3 months’ supply, with 3 repeats.
Click here for more information about the Personal Importation Scheme.
Nicovape’s revolutionary eHealth platform provides Australia’s first fully legal, home delivered, end-to-end iNRT prescription and supply model. No longer do patients have to run the risk of importing unknown products illegally from overseas websites or purchasing nicotine containing eliquids illegally under the counter from unscrupulous local retailers. Our online eHealth model provides convenient and legal access to iNRT products to all your suitable patients, and leaves you, their local doctor, removed from the prescribing process and protected from liability.
A letter to doctors from Nicovape’s Medical Director
Your smoking patients have tried every available option on the market to quit smoking, yet in the vast majority of cases, most of them have relapsed. In some cases, you may have even given up talking to them about it. You may also have considered suggesting e-cigarettes as a last-ditch attempt, but don’t know how to do it safely and in a way where you are fully protected legally. Since there aren't any products currently listed on the ARTG, there's the added concern of not knowing whether products have been manufactured to suitable medical standards. It’s a real mess of confusion out there.
With the launch of Nicovape’s new iNRT service, your patients can find hope again with our revolutionary smoking alternative products. Even completely pre-contemplative patients are often very interested in this option, and your conversation with them becomes much easier. You can talk about it with even the most recalcitrant patients, because you are not discussing the dreaded topic of "quitting", or pressuring them to stop something that they enjoy, but rather suggesting a reduced harm alternative by directing them to our website.
Patients find this refreshing and empowering, unlike the standard quit smoking discussions you dread, and which so often don’t work.
You can recommend Nicovape’s iNRT products and services with both confidence and complete peace of mind, with the knowledge that our online eHealth consultation is performed completely separately from yourself and your medical practice. Our affiliated prescribing doctors take full responsibility for the online eHealth consultations performed on the Nicovape website, and for any subsequently issued prescriptions. After comprehensive review from Australian medical indemnity insurers, our eHealth platform has been assessed and approved to issue prescriptions under existing telehealth insurance provisions. Furthermore, we are also the only company in the Australasian region to obtain full, locally issued product liability insurance coverage.
Our QWIT. product is not only designed to pharmaceutical standards, but with its unique benefits of being discreet and extremely simple to use, and furthermore featuring high nicotine concentration formulations intended to assist with complete smoking cessation and also to prevent relapse or dual use, it is an ideal substitute for smoking, and is designed specifically to meet smokers needs.
Our product is inherently safer than everything else on the Australian market because the volume of vapor is kept to a minimum and is vaporised at the lowest possible temperature, without affecting the satisfaction or nicotine delivery effectiveness that our products provide. We are continually improving our products and subjecting them to independent medical and scientific analysis to further reduce any unnecessary emissions. We source only the highest quality ingedients to produce our liquids in our very own laboratory in Auckland, New Zealand which complies with all Good Manufacturing Principles (GMP) standards and places product quality and user safety as our highest priority. .
It is currently estimated that vaping the current mainstream e-cigarette products is at most, 5% of the risk compared to cigarettes. Here at Nicovape, we are determined to reduce this even further. Led by our team of fully Australian qualified and Australian registered Doctors and Pharmacists, we strive to make the emissions of our products, especially trace metals and aldehydes, down to levels that are either undetectable, or well below established occupational safety limits. Our goal is that the estimated relative risk to a patient who fully switches to our iNRT products will be under 1% of the comparable risk of smoking.
The only thing you need to do to help your smoking patients is simply direct them to our website. With your ongoing, in person support, you can now finally help many of your patients who have struggled with their insidious cigarette addiction for so long, and help them to make the best decision of their lives, to quit smoking.
We encourage you to contact us if you have any further medical related questions, which will be answered personally by our Medical Director, Dr Attila Danko.
Interested in being one of our prescribing doctors?